AMGN vs BIIB: Side-by-Side Comparison
Compare AMGEN Inc (AMGN) and Biogen Inc (BIIB) side by side: market cap USD 201.93B vs USD 31.91B, P/E 26.0 vs 23.2. Financials, growth and model signals on Bullrun.
| Metric | AMGN | BIIB |
|---|---|---|
| Company | AMGEN Inc | Biogen Inc |
| Country / Exchange | United States · NASDAQ | United States · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 201.93B | USD 31.91B |
| P/E ratio | 26.0 | 23.2 |
| Dividend yield | 2.62% | — |
| Valuation model | 4.2% undervalued | 5.7% undervalued |
| Revenue (FY2025) | USD 36.75B | USD 9.89B |
| Revenue growth YoY | +10.0% | +2.2% |
| Net income | USD 7.71B | USD 1.29B |
| Gross margin | 67.2% | 75.7% |
| Diluted EPS | 14.23 | 8.79 |